At HLTH 2024, I had dozens of conversations with providers, investors and digital health startup executives. Here are seven refreshingly honest takes I heard from them.
Seaport Therapeutics' Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more.
We should use AI to develop recommendations for breast cancer screening protocols based on quantified risk, factoring in family history, ethnicity, genetics, and density, et al. – and then support the use of powerful new imaging AI technologies for those cases that demand a deeper look.
The new standards emphasize the need for strong reporting and analytics that go beyond just credentialing automation. Healthcare organizations must look for solutions with comprehensive self-serve reporting capabilities to improve access and visibility into activities like potential changes to data, monitoring gaps, and more.
The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant.
No comments